For the survey, the nonprofit alliance asked pharmaceutical and life science leaders about their attitudes toward blockchain deployment.
Here are four survey insights.
1. The majority of respondents (83 percent) expect to adopt blockchain technologies within five years.
2. Challenges like regulatory issues (45 percent) and data privacy (26 percent) currently stand in the way of implementation, according to respondents.
3. Sixty-eight percent of respondents said the No. 1 area blockchain will have a significant impact on is supply chain.
4. The second most commonly cited area respondents said blockchain would impact is medical record storage (60 percent).
More articles on health IT:
Boston security researcher discovers ‘vaccine’ for Petya ransomware: 4 things to know
Top 5 personality traits of Google, IBM & Oracle CEOs
IBM Watson SVP to Congress: AI dialogue should focus on positive impact, not ‘fear tactics’
